Elanco Animal Health Incorporated (ELAN)

13.36 -0.10 (-0.74%) As of 12:17PM EDT. Market open.

Elanco Animal Health Incorporated

2500 Innovation Way
Greenfield, IN 46140
United States
877 352 6261
https://www.elanco.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 9,300

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jeffrey N. Simmons	President, CEO & Director	2.46M	N/A	1967
Dr. Ellen de Brabander Ph.D.	Executive Vice President of Innovation, Regulatory & Business Development	1.14M	N/A	1963
Mr. James M. Meer	Senior VP & Chief Accounting Officer	N/A	N/A	1970
Mr. Chris Keeley	Senior VP & Chief Information Officer	N/A	N/A	N/A
Mr. David S. Kinard	Executive Vice President of Human Resources, Corporate Communications & Administration	722.58k	N/A	1967
Katy Grissom	Head of Investor Relations	N/A	N/A	N/A
Mr. Larbi Van Lier	Senior Vice President of Asia	N/A	N/A	N/A
Michelle Calvo-Lorenzo	Chief Animal Welfare Officer	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Corporate governance

Elanco Animal Health Incorporated’s ISS governance QualityScore as of 1 April 2024 is 7. The pillar scores are Audit: 8; Board: 8; Shareholder rights: 7; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.